A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study

References

• Dasari A , ShenC, HalperinDet al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol.3(10), 1335–1342 (2017).
   PubMed Web of Science ®Google Scholar
• Cives M , StrosbergJR. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J. Clin.68(6), 471–487 (2018).
   PubMed Web of Science ®Google Scholar
• Bilimoria KY , TomlinsonJS, MerkowRPet al. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J. Gastrointest. Surg.11(11), 1460–1467; discussion 1467–1469 (2007).
   PubMed Web of Science ®Google Scholar
• Lloyd RV , OsamuraRY, GK, JR. WHO classification of tumours of endocrine organs – Chapter 6 Neoplasms of the neuroendocrine pancreas. (4th Edition). IARC Press, Lyon, France10, 209–210 (2017).
   Google Scholar
• Brooks JC , ShavelleRM, Vavra-MusserKN. Life expectancy in pancreatic neuroendocrine cancer. Clin. Res. Hepatol. Gastroenterol.43(1), 88–97 (2019).
   PubMed Web of Science ®Google Scholar
• Yao JC , HassanM, PhanAet al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol.26(18), 3063–3072 (2008).
   PubMed Web of Science ®Google Scholar
• Halfdanarson TR , RabeKG, RubinJ, PetersenGM. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann. Oncol.19(10), 1727–1733 (2008).
   PubMed Web of Science ®Google Scholar
• Cai W , TanY, GeW, DingK, HuH. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study. Cancer Med.7(6), 2699–2709 (2018).
   PubMed Web of Science ®Google Scholar
• Goretzki PE , MoglMT, AkcaA, PratschkeJ. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract. Rev. Endocr. Metab. Disord.19(2), 169–178 (2018).
   PubMed Web of Science ®Google Scholar
• Huang PY , TsaiKL, LiangCMet al. Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms. Kaohsiung J. Med. Sci.34(11), 650–656 (2018).
   PubMed Web of Science ®Google Scholar
• Feng T , LvW, YuanMet al. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma. World J. Surg. Oncol.17(1), 54 (2019).
   PubMedGoogle Scholar
• Fang C , WangW, FengXet al. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Br. J. Cancer117(10), 1544–1550 (2017).
   PubMed Web of Science ®Google Scholar
• Merath K , BaganteF, BealEWet al. Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: an analysis of the U.S. Neuroendocrine Tumor Study Group. J. Surg. Oncol.117(5), 868–878 (2018).
   PubMed Web of Science ®Google Scholar
• Cao LL , LuJ, LinJXet al. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms. World J. Gastroenterol.23(47), 8376–8386 (2017).
   PubMed Web of Science ®Google Scholar
• Miao DL , SongW, QianJet al. Development and validation of a nomogram for predicting overall survival in pancreatic neuroendocrinetumors. Transl. Oncol.11(5), 1097–1103 (2018).
   PubMed Web of Science ®Google Scholar
• Ruzzenente A , BaganteF, BertuzzoFet al. A novel nomogram to predict the prognosis of patients undergoing liver resection for neuroendocrine liver metastasis: an analysis of the italian neuroendocrine liver metastasis database. J. Gastrointest. Surg.21(1), 41–48 (2017).
   PubMed Web of Science ®Google Scholar
• Ye L , YeH, ZhouQet al. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: new proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases. Int. J. Surg.29, 108–117 (2016).
   PubMed Web of Science ®Google Scholar
• Kloppel G , CouvelardA, PerrenAet al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology90(2), 162–166 (2009).
   PubMed Web of Science ®Google Scholar
• Pelosi G , BresaolaE, BoginaGet al. Endocrine tumors of the pancreas: ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone recep tor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum. Pathol.27(11), 1124–1134 (1996).
   PubMed Web of Science ®Google Scholar
• Rindi G , KloppelG, AlhmanHet al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch.449(4), 395–401 (2006).
   PubMed Web of Science ®Google Scholar
• Perren A , CouvelardA, ScoazecJYet al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification. Neuroendocrinology105(3), 196–200 (2017).
   PubMed Web of Science ®Google Scholar
• AA K , JEZ. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit. Care Med.35(9), 2052–2056 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang X , SongJ, LiuPet al. A modified M-stage classification based on the metastatic patterns of pancreatic neuroendocrine neoplasms: a population-based study. BMC Endocr. Disord.18(1), 73 (2018).
   PubMedGoogle Scholar
• Colquhoun SD . Neuroendocrine tumors with hepatic metastases: a review of evolving treatment options. Liver Res.2(2), 92–99 (2018).
   Google Scholar
• Watzka FM , FottnerC, MiedererMet al. Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis. Langenbecks Arch. Surg.400(3), 349–358 (2015).
   PubMed Web of Science ®Google Scholar
• Halperin DM , YaoJC, ArvindDasari. What's in a name? Steady progress in staging pancreatic neuroendocrine tumors. J. Clin. Oncol.35(3), 265–267 (2017).
   PubMed Web of Science ®Google Scholar
• Man D , WuJ, ShenZ, ZhuX. Prognosis of patients with neuroendocrine tumor: a SEER database analysis. Cancer Manag. Res.10, 5629–5638 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang C , WuY, ZhuangHet al. Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection. Cancer Manag. Res.11, 7345–7352 (2019).
   PubMed Web of Science ®Google Scholar
• Wen J , ChenJ, LiuDet al. The eighth edition of the American Joint Committee on Cancer (AJCC) distant metastases (M) stage classification for metastatic pancreatic neuroendocrine tumors might be feasible for metastatic pancreatic ductal adenocarcinomas. Neuroendocrinology doi: 10.1159/000502382 (2019) ( Epub ahead of print).
   Google Scholar
• Wu J , SunC, LiEet al. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality. BMC Cancer19(1), 334 (2019).
   PubMedGoogle Scholar
• Sackstein PE , O'NeilDS, NeugutAI, ChabotJ, FojoT. Epidemiologic trends in neuroendocrine tumors: an examination of incidence rates and survival of specific patient subgroups over the past 20 years. Semin. Oncol.45(4), 249–258 (2018).
   PubMed Web of Science ®Google Scholar
• Zhai H , LiD, FengQet al. Pancreatic neuroendocrine tumours: grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy: a retrospective cohort study in the SEER database. Int. J. Surg.66, 103–109 (2019).
   PubMed Web of Science ®Google Scholar
• Tang LH , UntchBR, ReidyDLet al. Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas. Clin. Cancer Res.22(4), 1011–1017 (2016).
   PubMed Web of Science ®Google Scholar
• Mayo SC , de JongMC, PulitanoCet al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann. Surg. Oncol.17(12), 3129–3136 (2010).
   PubMed Web of Science ®Google Scholar
• Lesurtel M , NagorneyDM, MazzaferroV, JensenRT, PostonGJ. When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations. HPB (Oxford).17(1), 17–22 (2015).
   PubMed Web of Science ®Google Scholar
• He CB , ZhangY, CaiZY, LinXJ. The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis. Endocr. Connect.8(3), 239–251 (2019).
   PubMed Web of Science ®Google Scholar
• Ramage JK , AhmedA, ArdillJet al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut61(1), 6–32 (2012).
   PubMed Web of Science ®Google Scholar
• Keutgen XM , NilubolN, GlanvilleJet al. Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors. Surgery159(1), 311–318 (2016).
   PubMed Web of Science ®Google Scholar
• He C , ZhongL, ZhangY, CaiZ, LinX. Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study. Cancer Manag. Res.11, 3981–3991 (2019).
   PubMed Web of Science ®Google Scholar